I think that's what Mr. Erskine-Smith alluded to as well, which is that based on what we're going to study, it might be a recommendation in our review of PIPEDA. But Mr. Blaikie's point is that it is a unique enough item that it might still be worth studying in its own right after that.
Because we don't know what's going to happen during our PIPEDA review, we can't make the determination right now, but we do have a motion on the floor. That doesn't mean that if it's not dealt with through PIPEDA we couldn't change our minds later on and not do the study. We have that ability as a committee.
For the time being, I need some direction on whether or not to add the proposed study by Mr. Blaikie to our work plan.